Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,882 | 618 | 97.0% |
| Education | $155.45 | 6 | 1.5% |
| Consulting Fee | $150.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,119 | 60 | $0 (2024) |
| Lundbeck LLC | $1,049 | 70 | $0 (2024) |
| ABBVIE INC. | $954.04 | 63 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $854.57 | 47 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $813.59 | 58 | $0 (2022) |
| ITI, Inc. | $809.40 | 38 | $0 (2023) |
| Allergan, Inc. | $716.49 | 55 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $689.50 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $643.37 | 41 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $608.93 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,000 | 50 | Otsuka America Pharmaceutical, Inc. ($258.30) |
| 2023 | $1,798 | 98 | ITI, Inc. ($383.68) |
| 2022 | $1,224 | 74 | Teva Pharmaceuticals USA, Inc. ($187.53) |
| 2021 | $1,546 | 87 | AbbVie Inc. ($333.84) |
| 2020 | $782.40 | 47 | Allergan, Inc. ($180.04) |
| 2019 | $1,234 | 81 | Allergan Inc. ($216.33) |
| 2018 | $1,274 | 98 | Lundbeck LLC ($188.66) |
| 2017 | $1,330 | 90 | Lundbeck LLC ($289.92) |
All Payment Transactions
625 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.03 | General |
| 08/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: CNS | ||||||
| 08/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Neuropsychiatry | ||||||
| 07/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: CNS | ||||||
| 06/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Central Nervous System | ||||||
| 06/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Neuropsychiatry | ||||||
| 05/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Neuroscience | ||||||
| 05/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 132 | 243 | $56,030 | $16,053 |
| 2022 | 3 | 102 | 187 | $44,110 | $13,703 |
| 2021 | 3 | 119 | 252 | $55,170 | $16,999 |
| 2020 | 3 | 117 | 236 | $47,620 | $12,423 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 91 | $21,840 | $5,777 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 56 | $15,120 | $4,324 | 28.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 29 | 50 | $11,250 | $3,557 | 31.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 35 | 46 | $7,820 | $2,395 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 110 | $29,700 | $9,318 | 31.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 32 | 49 | $8,330 | $2,673 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 28 | $6,080 | $1,712 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 108 | $29,160 | $9,144 | 31.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 39 | 93 | $15,810 | $4,939 | 31.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 51 | $10,200 | $2,915 | 28.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 42 | 91 | $15,470 | $4,929 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 100 | $20,000 | $4,326 | 21.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 45 | $12,150 | $3,169 | 26.1% |
About Dr. Fiona Mudge, MD
Dr. Fiona Mudge, MD is a Psychiatry healthcare provider based in Randolph, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417933888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fiona Mudge, MD has received a total of $10,188 in payments from pharmaceutical and medical device companies, with $1,000 received in 2024. These payments were reported across 625 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($9,882).
As a Medicare-enrolled provider, Mudge has provided services to 470 Medicare beneficiaries, totaling 918 services with total Medicare billing of $59,178. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Randolph, MA
- Active Since 12/19/2005
- Last Updated 09/17/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1417933888
Products in Payments
- VRAYLAR (Drug) $1,671
- REXULTI (Drug) $1,647
- CAPLYTA (Drug) $881.16
- INGREZZA (Drug) $854.57
- LATUDA (Drug) $813.59
- TRINTELLIX (Drug) $556.61
- SPRAVATO (Drug) $480.59
- AUSTEDO (Drug) $362.65
- ARISTADA (Drug) $347.96
- Trintellix (Drug) $252.10
- Hetlioz (Drug) $245.49
- Fanapt (Drug) $204.00
- VYVANSE (Drug) $202.02
- BRINTELLIX (Drug) $192.67
- HETLIOZ (Drug) $185.05
- Austedo XR (Drug) $162.78
- APLENZIN (Drug) $148.10
- Azstarys (Drug) $133.85
- ABILIFY MAINTENA (Drug) $126.87
- LYBALVI (Drug) $94.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Randolph
Gary Warstadt, Md, MD
Psychiatry — Payments: $9,315
Edith Pepper
Psychiatry — Payments: $6,861
Dean Solomon, Md, MD
Psychiatry — Payments: $5,893
Dr. Krishnaswamy Gajaraj, M.d, M.D
Psychiatry — Payments: $1,881
Leonard Marcus, Md, MD
Psychiatry — Payments: $677.08
Dr. Michael Krysko, Md, MD
Psychiatry — Payments: $489.58